Literature DB >> 23426425

Trends in national rotavirus activity before and after introduction of rotavirus vaccine into the national immunization program in the United States, 2000 to 2012.

Jacqueline E Tate1, Amber Haynes, Daniel C Payne, Margaret M Cortese, Benjamin A Lopman, Manish M Patel, Umesh D Parashar.   

Abstract

BACKGROUND: Rotavirus vaccine introduction in the United States in 2006 led to substantial declines in rotavirus detections during 2007 to 2010. To further evaluate the long-term impact of the vaccine program, we assessed trends in rotavirus testing and detection in the 2010 to 2011 and 2011 to 2012 seasons compared with prevaccine seasons from 2000 to 2006.
METHODS: We examined data from July 2000 to June 2012 from 50 to 70 laboratories reporting to the National Respiratory and Enteric Viruses Surveillance System to compare rotavirus season timing and peak activity in the pre- and postvaccine introduction eras. To assess trends in rotavirus testing and detection, we restricted the analyses to 25 laboratories that consistently reported for ≥ 26 weeks for each season from 2000 to 2012.
RESULTS: The threshold for the start of the rotavirus season was never achieved nationally during the 2011 to 2012 season, and the 2010 to 2011 season was 8 weeks shorter in duration than the prevaccine baseline. During these seasons, nationally, the number of positive rotavirus tests declined 74%-90% compared with the prevaccine baseline and the total number of tests performed annually declined 28%-36%. The annual proportion positive at the 25 consistently reporting laboratories remained below 10% in both seasons compared with a prevaccine baseline median of 26%. A pattern of biennial increases in rotavirus activity emerged during the 5 postvaccine seasons from 2007 to 2012, but activity remained substantially below prevaccine levels.
CONCLUSIONS: A substantial and sustained decline in rotavirus activity below the prevaccine baseline was observed in all 5 postvaccine introduction years, affirming the long-term health benefits of the US rotavirus vaccination program.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23426425     DOI: 10.1097/INF.0b013e31828d639c

Source DB:  PubMed          Journal:  Pediatr Infect Dis J        ISSN: 0891-3668            Impact factor:   2.129


  25 in total

1.  First assessment of all-cause acute diarrhoea and rotavirus-confirmed cases following massive vaccination in Argentina.

Authors:  J I Degiuseppe; J A Stupka
Journal:  Epidemiol Infect       Date:  2018-07-13       Impact factor: 2.451

2.  Pentavalent rotavirus vaccine in infants with surgical gastrointestinal disease.

Authors:  Eric J McGrath; Ron Thomas; Christopher Duggan; Basim I Asmar
Journal:  J Pediatr Gastroenterol Nutr       Date:  2014-07       Impact factor: 2.839

3.  Reverse Genetics System for a Human Group A Rotavirus.

Authors:  Takahiro Kawagishi; Jeffery A Nurdin; Misa Onishi; Ryotaro Nouda; Yuta Kanai; Takeshi Tajima; Hiroshi Ushijima; Takeshi Kobayashi
Journal:  J Virol       Date:  2020-01-06       Impact factor: 5.103

4.  Decline in Emergency Department Visits for Acute Gastroenteritis Among Children in 10 US States After Implementation of Rotavirus Vaccination, 2003 to 2013.

Authors:  Minesh P Shah; Jacqueline E Tate; Claudia A Steiner; Umesh D Parashar
Journal:  Pediatr Infect Dis J       Date:  2016-07       Impact factor: 2.129

5.  Trends in Infectious Disease Hospitalizations in US Children, 2000 to 2012.

Authors:  Tadahiro Goto; Yusuke Tsugawa; Jonathan M Mansbach; Carlos A Camargo; Kohei Hasegawa
Journal:  Pediatr Infect Dis J       Date:  2016-06       Impact factor: 2.129

Review 6.  Developments in understanding acquired immunity and innate susceptibility to norovirus and rotavirus gastroenteritis in children.

Authors:  Daniel C Payne; Umesh D Parashar; Benjamin A Lopman
Journal:  Curr Opin Pediatr       Date:  2015-02       Impact factor: 2.856

7.  Temporal association of rotavirus vaccination and genotype circulation in South Africa: Observations from 2002 to 2014.

Authors:  N A Page; L M Seheri; M J Groome; J Moyes; S Walaza; J Mphahlele; K Kahn; C N Kapongo; H J Zar; S Tempia; C Cohen; S A Madhi
Journal:  Vaccine       Date:  2017-10-27       Impact factor: 3.641

8.  Potential safety issues and other factors that may affect the introduction and uptake of rotavirus vaccines.

Authors:  N Aliabadi; J E Tate; U D Parashar
Journal:  Clin Microbiol Infect       Date:  2016-04-26       Impact factor: 8.067

9.  Human Intestinal Enteroids: a New Model To Study Human Rotavirus Infection, Host Restriction, and Pathophysiology.

Authors:  Kapil Saxena; Sarah E Blutt; Khalil Ettayebi; Xi-Lei Zeng; James R Broughman; Sue E Crawford; Umesh C Karandikar; Narayan P Sastri; Margaret E Conner; Antone R Opekun; David Y Graham; Waqar Qureshi; Vadim Sherman; Jennifer Foulke-Abel; Julie In; Olga Kovbasnjuk; Nicholas C Zachos; Mark Donowitz; Mary K Estes
Journal:  J Virol       Date:  2015-10-07       Impact factor: 5.103

10.  Rotavirus vaccines: why continued investment in research is necessary.

Authors:  Michelle M Arnold
Journal:  Curr Clin Microbiol Rep       Date:  2018-01-18
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.